|
Volumn 301, Issue 3, 2002, Pages 1020-1024
|
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor
a,b b a a a b a a,b a b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANANDAMIDE;
ARACHIDONIC ACID DERIVATIVE;
CANNABINOID 1 RECEPTOR;
CANNABINOID RECEPTOR ANTAGONIST;
CARBON 14;
ESTER;
ETHANOLAMINE DERIVATIVE;
UNCLASSIFIED DRUG;
VIRODHAMINE;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BRAIN;
BRAN;
CELL STRAIN;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG STRUCTURE;
HIPPOCAMPUS;
HUMAN;
HUMAN TISSUE;
HYPOTHERMIA;
LIQUID CHROMATOGRAPHY;
MALE;
MASS SPECTROMETRY;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
STRUCTURE ANALYSIS;
ANIMALS;
ARACHIDONIC ACIDS;
BODY TEMPERATURE;
BRAIN;
CANNABINOIDS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOCANNABINOIDS;
ETHANOLAMINE;
HIPPOCAMPUS;
MALE;
MICE;
POLYUNSATURATED ALKAMIDES;
RATS;
RATS, WISTAR;
RECEPTOR, CANNABINOID, CB2;
RECEPTORS, CANNABINOID;
RECEPTORS, DRUG;
|
EID: 0036260823
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: 10.1124/jpet.301.3.1020 Document Type: Article |
Times cited : (510)
|
References (15)
|